Wednesday, April 26, 2017

Oxford Debate: Pharma using CROs vs not outsourcing clinical trials


Do pharma & biotech companies need CROs or is it better not to outsource clinical trials at all? In recent years, partnerships and outsourcing have grown rapidly in popularity, promising cheaper, faster, more successful trials. However, there are still plenty of challenges to be overcome and for some, these challenges are so numerous that they outweigh the benefits of such collaborations.

At Partnerships in Clinical Trials Europe 2016 four leading drug development professionals debated this vital question with an audience vote before and after. Watch the arguments above (or watch it here) and find out if they managed to sway an audience firmly behind the benefits of outsourcing.

Partnerships and Collaborations: Forming Alliances That Last is one of four streams at T3: Trials, Tech and Transformation on May 11-12 in Orlando, Florida. Use the exclusive code T3BLOG17 to save $200 on the cost of a pass. Find out more here.




No comments: